Dividend compounder review
ONC
BeiGene, Ltd. · NASDAQ · US
Healthcare · Biotechnology
Score46.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Quality breakdown
Dividend Reliability
0.0 / 25
Payment history, cuts, growth, and regularity.
Dividend Sustainability
17.0 / 20
Payout, free cash flow, dividend cover, and debt.
Business Quality
22.0 / 25
Scale, cash generation, growth, margins, and returns.
Valuation Discipline
3.5 / 15
Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend
4.0 / 15
Trend line, long return history, and drawdown control.
Dividend and business context
Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$286.9M
Free Cash Flow$861.0M
FCF Covers DividendUnknown
Debt / Equity0.24
P/E59.8
Revenue Growth 5Y76.8%
Net Margin8.9%
ROE12.4%
Price vs Trend-15.8%
3Y Return47.5%
5Y Return-27.2%
CurrencyUSD
Review flags
No usable dividend history found.
Activity record
No usable dividend history found.